Skip to content

한국오가논 – Organon Korea logo

Main menu
    • 한국오가논
    • Our Stories
    • 기업문화
      • 비전·가치·미션
      • 다양성·형평성·포용성
    • 경영진
    • ESG
    • 기업정책
    • 핵심사업
    • 제품리스트
  • 전문의 자료
    • 보도자료
    • 공지사항
  • 인재영입

고객문의

제품리스트

Visit Organon's LinkedIn Opens a new window Visit Organon's Instagram Opens a new window Visit Organon's YouTube Opens a new window

Main menu

Organon site directory

  • The Americas
    • Organon

      Brazil
      Canada  English  ·  French
      Latin America
      Mexico
      USA
  • Europe
    • Organon

      Austria
      Belgium  Dutch  ·  English  ·  French
      Czech Republic
      Denmark
      Finland
      France
      Germany
      Ireland
      Italy
      Luxembourg  English  ·  French
      Netherlands  Dutch  ·  English
      Norway
      Portugal
      Russia
      Spain
      Sweden
      Switzerland
      United Kingdom
  • Asia Pacific
    • Organon

      Australia
      Hong Kong, China
      Indonesia
      Japan
      Malaysia
      New Zealand
      Philippines
      Singapore
      South Korea
      Taiwan
      Thailand
      Vietnam
  • Middle East & Africa
    • Organon

      Middle East  English  ·  Arabic
      Northwest Africa  French  ·  Arabic  ·  Turkey
      South Africa
View all locations and contact information
What can we help you find?
Search for:
한국오가논 - Organon Korea » Our focus » Products lists

품목별

심혈관계

– 이상지질혈증

아토젯™정 (에제티미브/아토르바스타틴)

바이토린™정 (에제티미브/심바스타틴)

이지트롤®정 (에제티미브)

조코®정 (심바스타틴)

– 고혈압

코자®정 (로사르탄 칼륨)

코자®엑스큐정 (로사르탄 칼륨/암로디핀 캄실산염)

코자®플러스정 (로사르탄 칼륨/히드로클로로티아지드)

호흡기

– 알레르기 비염 & 천식

싱귤레어®정, 싱귤레어®츄정

싱귤레어®세립 (몬테루카스트 나트륨)

에리우스®정 (데스로라타딘)

– 비염

나조넥스®나잘스프레이(모메타손푸로에이트)

근골격계

– 골다공증

포사맥스®70mg정(알렌드론산 나트륨)

포사맥스플러스TM정, 포사맥스플러스디TM정

– 골관절염

알콕시아®정30밀리그램(에토리콕시브)

피부과학 및 기타

– 탈모

프로페시아®정(피나스테리드)

– 피부질환

에로콤®크림(모메타손푸로에이트)

– 우울증

레메론®정 (미르타자핀)

레메론®솔탭정 (제피미르타자핀)

생식기 및 비뇨기과

– 양성 전립선 비대증

프로스카®정(피나스테리드)

– 폐경

리비알®정(티볼론)

– 임신/출산/피임

임플라논엔엑스티®이식제(에토노게스트렐)

오가루트란®주 (가니렐릭스아세트산염)

퓨레곤®펜주(폴리트로핀베타, 재조합난포자극호르몬)

Connect with us on social

Linkedin icon Opens a new window Instagram icon Opens a new window YouTube icon Opens a new window
한국오가논 – Organon Korea logo

Company

  • 한국오가논

Resources

  • 보도자료
  • 전문의 자료

Contact us

  • 고객문의
  • 글로벌 사업장
  • Forward-Looking Statement
  • Cookie Policy Opens a new window
  • 개인정보처리방침
  • Term of Use
© 2021 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies.

You are leaving Organon.com

Cancel Continue

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept